China Biotech Finance Watch: Luzhu Bags $43.5m In Hong Kong IPO

In the private market, eight Chinese biotechs raised a combined $116m in deals backed by venture capital and private equity firms over the past few weeks.

funding
Luzhu Biotech became the first biotech in 2023 to complete an IPO in Hong Kong • Source: Shutterstock

More from China

More from Focus On Asia